NEW YORK, June 1, 2015 /PRNewswire/ — Centinel Spine, Inc. (Centinel Spine), the pioneer of spinal Stand-Alone, No-Profile®, Integrated Interbody™ devices has now implanted 20,000 STALIF
C cervical Integrated Interbody devices. The STALF C device is implanted during cervical fusion procedures to treat degenerative spinal disorders.
“This is an important milestone for Centinel Spine and our STALIF C product family. It represents our proven success and heritage of healing in anterior column support procedures,” said John Viscogliosi, CEO and President of Centinel Spine. “We are pleased at the continued adoption of our STALIF® technology as we strive to meet our vision of becoming the leading anterior column support spine franchise.”
Due to proven biomechanics, and now the Ti-ACTIVE™ coating, surgeons are increasingly using STALIF C and STALIF C-Ti™ Integrated Interbody devices instead of traditional plate and interbody combinations for their cervical fusion procedures. STALIF C offers surgeons and patients consistent clinical results with only a single incision procedure that is minimally invasive and tissue sparing.
“In my clinical experience utilizing the STALIF C device for over five years, it has been shown to be very effective in treating my degenerative spine patients,” said Dr. Said Elshihabi, WellStar Neurosurgery, Marietta, Georgia.
Dr. Elshihabi continues, “STALIF C offers my patients a proven technology with less metal, less tissue trauma and equivalent bio-mechanical strength to traditional implants. Ti-ACTIVE coated STALIF C-Ti represents Centinel’s commitment of being a leader in this space and providing patients with state of the art implant technology.”
The No-Profile STALIF C Integrated Interbody System was designed to simplify surgery and reduce the number of surgical steps required. This design also allows the device to nest fully within the confines of the vertebral body, leaving the anatomy unchanged external to the interbody. The STALIF C three-screw construct features the Anti Back-Out® technology, provides compressive fixation at the graft site and is proven to be biomechanically equivalent to a cage and plate.1,2
STALIF C and the complete STALIF® product family continue to raise the gold standard in Integrated Interbody technology.
1. Cappuccino A, MD; Cunningham BW, Multi-directional flexibility properties of the STALIF C versus conventional methods of interbody cervical arthrodesis: an in-vitro calf spine model. November 2007.
2. Stein MI, et al.; Biomechanics of an Integrated Interbody device versus ACDF anterior locking plate in a single-level cervical spine fusion construct. Spine J., January 2014; 14(1):128-136.
About Centinel Spine, Inc.
Centinel Spine, Inc. (Centinel Spine) is a privately-held spinal device company leading the development and commercialization of the No Profile Integrated Interbody fusion technologies. For more information on Centinel Spine products and technologies, please visit the Company’s web site at www.centinelspine.com.
The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generating superior clinical outcomes.
Centinel Spine derived its name from the “Sentinel Sign” – the radiographic confirmation of a successful fusion anterior to the interbody device.
For more information, please contact:
Michael Heraghty
Centinel Spine, Inc.
900 Airport Road, Suite 3B
West Chester, PA 19380
484-887-8810
Email: [email protected]
SOURCE Centinel Spine, Inc.
RELATED LINKS
http://www.centinelspine.com